https://scholars.lib.ntu.edu.tw/handle/123456789/632722
標題: | Role of α1-blockers in the current management of hypertension | 作者: | Li, Hua Xu, Ting-Yan Li, Yan Chia, Yook-Chin Buranakitjaroen, Peera Cheng, Hao-Min Van Huynh, Minh Sogunuru, Guru Prasad Tay, Jam Chin TZUNG-DAU WANG Kario, Kazuomi Wang, Ji-Guang |
關鍵字: | benign prostatic hyperplasia; hypertension; primary aldosteronism screen; resistant hypertension; α1-blocker | 公開日期: | 九月-2022 | 卷: | 24 | 期: | 9 | 起(迄)頁: | 1180 | 來源出版物: | Journal of clinical hypertension (Greenwich, Conn.) | 摘要: | There is emerging evidence that α1-blockers can be safely used in the treatment of hypertension. These drugs can be used in almost all hypertensive patients for blood pressure control. However, there are several special indications. Benign prostatic hyperplasia is a compelling indication of α1-blockers, because of the dual treatment effect on both high blood pressure and lower urinary tract symptoms. Many patients with resistant hypertension would require α1-blockers as add-on therapy. Primary aldosteronism screen is a rapidly increasing clinical demand in the management of hypertension, where α1-blockers are useful for blood pressure control in the preparation for the measurement of plasma aldosterone and renin. Nonetheless, α1-blockers have to be used under several considerations. Among the currently available agents, only long-acting α1-blockers, such as doxazosin gastrointestinal therapeutic system 4-8 mg daily and terazosin 2-4 mg daily, should be chosen. Orthostatic hypotension is a concern with the use of α1-blockers especially in the elderly, and requires careful initial bedtime dosing and avoiding overdosing. Fluid retention is potentially also a concern, which may be overcome by combining an α1-blocker with a diuretic. |
URI: | https://www.scopus.com/record/display.uri?eid=2-s2.0-85139446011&doi=10.1111%2fjch.14556&origin=inward&txGid=eb467851d459ce00988fb56c598ad114 https://scholars.lib.ntu.edu.tw/handle/123456789/632722 |
ISSN: | 15246175 | DOI: | 10.1111/jch.14556 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。